Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Mitacs | Natural Sciences and Engineering Research Council, Canada
Deal Size : Inapplicable
Deal Type : Inapplicable
Improving Iron Levels in Female Endurance, Intermittent, and Power/Strength Athletes Aged 16-35
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 24, 2025
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Mitacs | Natural Sciences and Engineering Research Council, Canada
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Low Birth Weight.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 15, 2024
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Daily Oral Iron Supplementation for Replenishment of Depleted Iron in Adults
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
January 11, 2022
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Premenopause.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 02, 2021
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Gencor Pacific Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs
Details : Ferrous Sulphate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 10, 2020
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Gencor Pacific Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Unity Health Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 31, 2018
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Unity Health Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Daily vs Intermittent Iron Therapy in Pregnancy
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia, Iron-Deficiency-associated with Pregnancy.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 16, 2018
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 15, 2018
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol
Details : Fer-In-Sol (Ferrous Sulfate) is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Fer-In-Sol
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
September 19, 2016
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fer-In-Sol (Ferrous Sulfate) is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Fer-In-Sol
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 10, 2016
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable